tiprankstipranks
Trending News
More News >
Emcure Pharmaceuticals Limited (IN:EMCURE)
:EMCURE
India Market

Emcure Pharmaceuticals Limited (EMCURE) Financial Statements

Compare
2 Followers

Emcure Pharmaceuticals Limited Financial Overview

Emcure Pharmaceuticals Limited's market cap is currently ₹286.25B. The company's EPS TTM is ₹12.4; its P/E ratio is 28.05; and it has a dividend yield of 0.21%. Emcure Pharmaceuticals Limited is scheduled to report earnings on February 5, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25
Income Statement
Total Revenue₹ 78.08B
Gross Profit₹ 275.05M
Operating Income₹ 10.85B
EBITDA₹ 14.95B
Net Income₹ 6.81B
Balance Sheet
Cash & Short-Term Investments₹ 1.98B
Total Assets₹ 82.33B
Total Debt₹ 10.23B
Net Debt₹ 9.01B
Total Liabilities₹ 35.91B
Stockholders' Equity₹ 44.46B
Cash Flow
Free Cash Flow₹ 4.45B
Operating Cash Flow₹ 8.52B
Investing Cash Flow₹ -940.01M
Financing Cash Flow₹ -8.14B
Currency in INR

Emcure Pharmaceuticals Limited Earnings and Revenue History

Emcure Pharmaceuticals Limited Debt to Assets

Emcure Pharmaceuticals Limited Cash Flow

Emcure Pharmaceuticals Limited Forecast EPS vs Actual EPS